Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Urinary Tract Infection

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 6 articles:
HTML format



Single Articles


    December 2019
  1. LABUDA LA, Adegnika AA, Rosa BA, Martin J, et al
    A praziquantel treatment study of immune and transcriptome profiles in Schistosoma haematobium-infected Gabonese schoolchildren.
    J Infect Dis. 2019 Dec 17. pii: 5679496. doi: 10.1093.
    PubMed     Abstract available


  2. TOOR J, Rollinson D, Turner HC, Gouvras A, et al
    Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
    J Infect Dis. 2019 Dec 12. pii: 5673803. doi: 10.1093.
    PubMed     Abstract available


    December 2018
  3. DUPNIK KM, Lee MH, Mishra P, Reust MJ, et al
    Altered cervical mucosal gene expression and lower IL-15 levels in women with S. haematobium but not S. mansoni infection.
    J Infect Dis. 2018 Dec 25. pii: 5260846. doi: 10.1093.
    PubMed     Abstract available


    August 2017
  4. ERMAN A, Hergouth VK, Blango MG, Kos MK, et al
    Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders.
    J Infect Dis. 2017;216:375-381.
    PubMed     Abstract available


    December 2016
  5. SULLIVAN MJ, Leclercq SY, Ipe DS, Carey AJ, et al
    The Streptococcus agalactiae virulence regulator CovR affects the pathogenesis of urinary tract infection.
    J Infect Dis. 2016 Dec 23. pii: jiw589. doi: 10.1093.
    PubMed     Abstract available


    September 2015
  6. POOLMAN JT, Wacker M
    Extra-intestinal Pathogenic Escherichia coli (ExPEC), a common human pathogen: challenges for vaccine development and progress in the field.
    J Infect Dis. 2015.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Urinary Tract Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: